Invus
6 rounds tracked since 12 January 2026.
- Rounds
- 6
- Led
- 0
- Capital in these rounds
- $1.1B
Sectors
Countries
Rounds
- Matchpoint TherapeuticsDevelops oral covalent medicines for autoimmune and inflammatory diseases $150MSeries B · 7 Oct
- Precision NeuroscienceDevelops brain-computer interfaces and implantable neural electrode systems $250MSeries D · 24 Sept
- Encoded TherapeuticsDevelops precision genetic medicines for severe neurological disorders as a clinical-stage biotechnology company. $275MSeries F · 9 Sept
- Flare TherapeuticsDiscovers and develops precision medicines by targeting transcription factors, focusing on prostate cancer. $85MSeries C · 30 Jun
- Ray TherapeuticsDevelops treatments aimed at restoring vision in people with retinal disease. $125MSeries B · 21 Apr
- MiradorDevelops clinical-stage therapies for immuno-fibrotic diseases through a multi-asset pipeline $250MSeries B · 12 Jan
Often invests with
The Daily Raise
The day's rounds in your inbox each morning.
Subscribe to The Daily Raise